Riskpilot← Back to searchSign inGet full accessNEMUS ARENDAL AS
ASActiveOrg 899523482.etasje 4, 4836 ArendalTraditional, complementary and alternative medicine activities · NACE 8696Est. 20135 employeesnemus.no
Revenue 2024
NOK 8,8M
-5% vs 2023
EBITDA margin
4.8%
-47% vs 2023
Equity ratio
37.7%
Financial strength
Net profit 2024
NOK 274K
-53% vs 2023
| Revenue | NOK 8,8M | -5% |
| EBITDA | NOK 416K | -47% |
| Net profit | NOK 274K | -53% |
| Total assets | NOK 1,6M | -12% |
| Equity | NOK 598K | -27% |
| Employees | 5 | — |
Legal name
NEMUS ARENDAL AS
Org number
899523482
Legal form
Aksjeselskap
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
15. januar 2013
Share capital
NOK 45 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Drive medisinske og administrative servicefunksjoner i tilknyttning til sentrets kiropraktorer, og andre leietakeres virksomheter.
Address
.etasje 4, 4836 Arendal
Phone
+4737004444
Email
post@nemus.no
Website
nemus.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 021 | 7 295 | 8 339 | 9 178 | 8 753 |
| Staff expenses | −2 003 | −3 211 | −508 | −489 | −497 |
| EBITDA | 1 096 | 142 | 287 | 789 | 416 |
| Depreciation & amort. | −35 | −23 | −29 | −36 | −62 |
| EBIT | 1 061 | 119 | 258 | 753 | 354 |
| Net financials | −3 | −1 | −0 | −1 | −1 |
| Profit before tax | 1 058 | 118 | 257 | 752 | 353 |
| Tax | 230 | 26 | 58 | 171 | 79 |
| Net profit | 827 | 92 | 199 | 581 | 274 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 277 | 1 803 | 1 747 | 1 805 | 1 585 |
| Equity | 503 | 594 | 543 | 824 | 598 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 774 | 1 209 | 1 203 | 981 | 987 |
| Total debt | 1 774 | 1 209 | 1 203 | 981 | 987 |
EBITDA margin
4.8%
This company
15.8%
Market median
-70% vs market
20202024
Equity ratio
37.7%
This company
38.2%
Market median
+1% vs market
20202024
Return on equity
45.8%
This company
18.4%
Market median
+149% vs market
20202024
Net profit margin
3.1%
This company
8.1%
Market median
-62% vs market
20202024
Asset turnover
5.52×
This company
1.12×
Market median
+393% vs market
20202024
Debt / equity
1.65×
This company
0.62×
Market median
-166% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2015 | |
| Chairman | 2015 | |
| Board of Directors | 2023 | |
| Board of Directors | 2015 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25% | 25% | 2024 | |
| Company | 25% | 25% | 2024 | |
| Company | 25% | 25% | 2024 | |
| Company | 25% | 25% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
C & C Chiro As
NEMUS ARENDAL AS Board members of NEMUS ARENDAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Helene Abusdal Moksness | Board of Directors | 0 companies |
| Lars-Christian Stig | Chairman | 0 companies |
| Nicolay Cornelius Høst | Board of Directors | 0 companies |
| Shannon Ranald Currie | Board of Directors | 0 companies |